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Human T lymphocyte ontogeny is a hierarchical 
thymic process in which the ordered somatic 
recombination of V, (D), and J gene segments at 
the TCR-, TCR-, TCR-, or TCR- loci 
determines the development into either  or 
 T cell lineages (Spits, 2002; Dik et al., 2005). 
TCR- rearrangement is the first to occur, at 
the CD34+, CD1a, CD4/8 double-negative 
(DN) stage, followed by concurrent TCR- 
and TCR- rearrangements coinciding with 
CD1a expression (Dik et al., 2005), and finally 
TCR- rearrangements, which occur at a later 
CD4/8 double-positive (DP) stage, accompanied 
by TCR- locus deletion due to V-J recom-
bination (Verschuren et al., 1997). All V, (D), and 
J gene segments are flanked with recombina-
tion signal sequences (RSSs) which are com-
posed of conserved heptamer and nonamer 
motifs separated by a nonconserved spacer of 
either 12 or 23 base pairs. The V(D)J recombi-
nation process is initiated by the multimeric 
RAG1–RAG2 complex (RAG1/2) which binds 
to a 12RSS/23RSS pair (12/23 rule) and then 
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V(D)J recombination of TCR loci is regulated by chromatin accessibility to RAG1/2 proteins, 
rendering RAG1/2 targeting a potentially important regulator of lymphoid differentiation. 
We show that within the human TCR-/ locus, D2-D3 rearrangements occur at a very 
immature thymic, CD34+/CD1a/CD7+dim stage, before D2(D3)-J1 rearrangements. 
These strictly ordered rearrangements are regulated by mechanisms acting beyond chroma-
tin accessibility. Importantly, direct D2-J1 rearrangements are prohibited by a B12/23 
restriction and ordered human TCR- gene assembly requires RUNX1 protein, which binds 
to the D2-23RSS, interacts with RAG1, and enhances RAG1 deposition at this site. This 
RUNX1-mediated V(D)J recombinase targeting imposes the use of two D gene segments in 
human TCR- chains. Absence of this RUNX1 binding site in the homologous mouse D1-
23RSS provides a molecular explanation for the lack of ordered TCR- gene assembly in 
mice and may underlie differences in early lymphoid differentiation between these species.
© 2014 Cieslak et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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which harbor the same RSS distribution (Fig. 1). Despite this, 
it is generally considered that TCR- gene rearrangements 
are not ordered in mice (Chiei et al., 1987; Krangel et al., 
2004), whereas it has been suggested that they could be or-
dered in human (Dik et al., 2005).
To better characterize the control of V(D)J recombination 
at the human TCR- locus, we have assessed the kinetics of 
TCR- gene assembly during the early stages of thymopoie-
sis. We report here that human TCR- gene rearrangements 
are controlled by a B12/23 restriction and are ordered. Im-
portantly the human but not mouse TCR- gene assembly 
ordering involves the TF RUNX1 which, through recruit-
ment to the D2-23RSS and interaction with RAG1, insures 
that D2-D3 rearrangement occurs before D3-J1 rear-
rangement. This specific RUNX1 D2-23RSS interaction 
might provide molecular insight into the difference between 
murine and human early T cell ontogeny.
RESULTS
Human D2-D3 rearrangements occur  
before D2-J1 rearrangements at a specific  
CD34+ CD7+dim CD5+/ early thymic stage
To determine whether human TCR- rearrangements are or-
dered, we first quantified early TCR- rearrangements (D2-
D3, D2-J1, and D3-J1) in sorted (Fig. S1) human thymic 
subpopulations and CD34+ umbilical cord blood (UCB) cells. 
As previously reported (Dik et al., 2005), D2-D3 rearrange-
ments were readily detected in CD34+/CD1a thymocytes, 
whereas D2-J1 rearrangements were detected at a lower level. 
In CD34+/CD1a+ thymocytes, D2-J1 rearrangement reached 
maximum levels and D2-D3 rearrangement declined (Fig. 2, 
A and B). In contrast, virtually no D3-J1 rearrangement was 
detected in human thymic subpopulations (Fig. 2 C).These 
observations were confirmed by quantification of the related 
T cell excision circles (Fig. 2, D and E) and fluorescent PCR 
analysis (Fig. 2 F). We next cultured UCB CD34+ cells on 
OP9-DL1 and analyzed TCR- rearrangement during cul-
ture. D2-D3 rearrangements were first detected at day 7, 
introduces double-strand breaks (DSBs) simultaneously at 
the two coding segment–RSS junctions (Eastman et al., 1996; 
van Gent et al., 1996). The subsequent repair phase involves 
the non-homologous end joining complex as well as the TdT 
(terminal deoxynucleotidyl transferase) enzyme which in-
creases antigen receptor diversity by adding N nucleotides at 
the coding segment junctions. The final products of V(D)J re-
combination are the CJ (coding joint) and the SJ (signal joint). 
In most cases, the latter is excised from the chromosome as a 
T cell receptor excision circle (TREC). Because TRECs are 
episomal and nonreplicative DNA, their quantity decreases 
during cell proliferation (Dik et al., 2005).
Regulation of V(D)J recombination is mediated by en-
hancer and promoter changes in chromatin structure which 
determine accessibility of the chromosomal RSS to RAG1/2 
complexes (Yancopoulos and Alt, 1985; Hesslein and Schatz, 
2001). In DN thymocytes, TCR- enhancer (E) activation 
controls chromatin accessibility to support TCR- rearrange-
ment (Bassing et al., 2003), whereas in DP thymocytes, activa-
tion of the TCR- enhancer (E) is indispensable for the 
initiation of TCR- rearrangement (Sleckman et al., 1997). 
Intrinsic RSS features can, however, be directly involved in 
the control of V(D)J recombination beyond chromatin acces-
sibility (Krangel, 2003). This has been clearly demonstrated 
for TCR- gene assembly. Indeed, direct V-J rearrange-
ment is prohibited by a mechanism operating beyond the 12/23 
rule and imposing D segment usage (Bassing et al., 2000). 
This B12/23 restriction is independent of chromatin struc-
ture; it is based on RSS features and can be fully recapitulated 
with in vitro systems using chromatin-free DNA ( Jung et al., 
2003; Tillman et al., 2003).
The B12/23 restriction imposes a two-step process for 
TCR- assembly but does not explain the ordering (D-J be-
fore V-DJ). It has recently been proposed that D 23RSS 
binds a transcription factor (TF), c-Fos, which efficiently re-
cruits RAG1 and enforces that D-J rearrangement occurs 
first (Wang et al., 2008). In both mice and humans, TCR- 
and TCR- loci contain D gene segments (Lefranc, 2001) 
Figure 1. TCR- configuration in humans 
and mice and the order of human thymic 
TCR rearrangements. (A) Schematic repre-
sentation of human and mouse TCR- loci. 
23RSS and 12RSS are represented, respec-
tively, in white and black triangles. (B) Thymic 
maturation stages and their TCR rearrange-
ments in humans.
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CD1a/CD7+dim and CD34+/CD1a/CD7++ subpopula-
tions (Fig. 3 A). As expected, the CD34+/CD1a/CD7+dim 
subset displayed an early T cell precursor (ETP) phenotype, 
based on weak CD5 expression and stem cell/myeloid anti-
gen expression (Fig. 3 B). Interestingly ETP cells harbored 
only D2-D3 rearrangements, whereas CD34+/CD1a/
CD7++ thymocytes exhibited both D2-D3 and D2-J1 
rearrangements (Fig. 3, C and D). D3-J1 rearrangements 
were not detected in these populations (Fig. 3 E). The moni-
toring of those rearrangements by multiplex fluorescent PCR 
analysis confirmed these data, and demonstrated that D2-D3 
followed by D2-J1 rearrangements 3 d later and again no 
D3-J1 rearrangement was identified (Fig. 2 G). To further 
confirm ordered TCR- rearrangement, we amplified, sub-
cloned, and sequenced D2-J1 human thymic rearrangements. 
D3 segments were detected in all D2-J1 rearrangements 
sequenced, suggesting that the assembly of D2 and J1 gene 
segments occurs in a two-step process which systematically 
includes the D3 gene segment (representative data in Fig. 2 H). 
To identify an early thymic stage specific to D2-D3 rear-
rangements, we sorted human CD4/8 DN/CD34+ thymic 
precursors based on the level of CD7 expression, into CD34+/
Figure 2. Kinetics of TCR- rearrangements during T cell development. (A–C) Quantification of D2-D3 (A), D2-J1 (B), and D3-J1 (C) rear-
rangements by RQ-PCR from CD34+ UCB, DN (34+1a and 34+1a+), immature SP (ISP), and DP thymocytes. Results (mean and SEM of triplicate reactions) 
are normalized to the Albumin gene throughout. (D and E) Quantification of D2-D3 (D) and D3-J1 (E) TREC by RQ-PCR. Presented data are from 
three experiments. Error bars represent SEM from three experiments. (F) Fluorescent PCR Genescan analysis (FI: fluorescence intensity) of D2-D3,  
D2-J1, and D3-J1 rearrangements present in sorted thymic populations. Data are representative of three experiments. (G) Quantification of  
D2-D3, D2-J1, and D3-J1 rearrangements at different days of CD34+ UCB culture on OP9-DL1. Presented data are from three independent experiments.  
(H) Sequence of D2-J1 thymic rearrangements. Data are representative of 52 sequences analyzed. D2, D3, and J1 segments are, respectively, in bold 
black, italic bold black, and gray highlight. Points represent deleted nucleotides. Inserted nucleotides during recombination are in gray.
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mouse D1 (homologous to human D2) and, as expected, no 
D1-23RSS enrichment was observed after RUNX1 ChIP in 
mouse Rag2/ DN thymocytes (Fig. 4 E). These data dem-
onstrate that RUNX1 can bind human D2-23RSS at a stage 
when D2 to D3 rearrangement is taking place.
RUNX1 interacts with RAG1 protein and  
enhances RAG1 deposition to the D2-23RSS
To explore further whether RUNX1 could interact with RAG 
proteins, streptavidin precipitation, coimmunoprecipitations 
(Co-IPs), and proximity ligation assays (PLAs) were performed. 
Streptavidin precipitation (StP) experiments demonstrated that 
RUNX1 protein, but not CBF-, interacts with and immuno-
precipitates RAG1 (Fig. 5 A). Furthermore, Co-IP assays using 
the MOLT-4 T lymphoblastic cell line, which coexpresses 
RUNX1 and RAG1, showed that IP performed with an anti-
RUNX1 antibody results in the Co-IP of RAG1, but not RAG2 
(Fig. 5 B). Finally, PLA confirmed the RUNX1–RAG1 inter-
action in MOLT-4 cells (Fig. 5 C) and showed that the inter-
action was lost after RUNX1 or RAG1 inactivation (Fig. 5 D). 
Importantly, PLA assays showed that RUNX1 interacts with 
RAG1 in CD34+ thymocytes (Fig. 5 E) and UCB cells co-
cultured on OP9-DL1 (Fig. 5, F and G) for 7 d (concurring with 
initiation of D2-D3 rearrangement, as shown in Fig. 2 G).
rearrangements start before D2-J1 rearrangements in a spe-
cific ETP subset (Fig. 3 F).
RUNX1 interacts with D2-23RSS
As D2 to D3 rearrangement occurs at a very immature stage 
of thymic maturation, harboring low levels of RAG transcripts 
(unpublished data), we hypothesized that early TCR- gene 
assembly requires a specific TF to allow efficient RAG1/2-
loading onto RSS, as described for c-Fos and D1 (Wang 
et al., 2008). To uncover putative TF binding sites within 
human D2, D3, and J1 RSS, an in silico analysis was per-
formed using the ConSite web-based tool. This identified 
a full consensus DNA binding site for RUNX1 (5TG(T/
C)GGT3) spanning the human D2-23RSS heptamer and 
D2 coding sequence (Fig. 4 A). No RUNX1 binding site was 
found in the other D and J RSS/coding sequences. RUNX1 
expression is high (at both transcript and protein levels) in 
human early thymic cells (Fig. 4, B and C) and as such coin-
cides with early TCR- gene rearrangement. Chromatin 
immunoprecipitation (ChIP) assays performed with human 
CD34+ thymocytes and anti-RUNX1 antibody show that im-
munoprecipitated DNA is significantly enriched with D2-
23RSS DNA, compared with D3-12RSS DNA (Fig. 4 D). 
Importantly, the RUNX1 binding site is not conserved in the 
Figure 3. D2-D3 rearrangements occur in the CD34+/CD1a/CD7+dim stage. (A) FACS plots showing the gating strategy used for sorting popu-
lations (dots and SD curves). Black and dashed boxes represent CD34+/CD1a/CD7+dim and CD34+/CD1a/CD7++ subpopulations, respectively. (B) FACS 
plots representing phenotypic markers differentially expressed between CD34+/CD1a/CD7+dim (blue) and CD34+/CD1a/CD7++ (orange) populations.  
(C–E) Quantification by RQ-PCR normalized to albumin (mean and SEM) of D2-D3 (C), D2-J1 (D), and D3-J1 (E) rearrangements. Data are repre-
sentative of three experiments. (F) Fluorescent PCR Genescan analysis (FI: fluorescence intensity) of D2-D3, D2-J1, and D3-J1 rearrangements. 
Data are representative of three experiments.
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the D3 gene segment. We hypothesized that a B12/23 re-
striction prohibits direct D2-J1 rearrangement. To explore 
such a possibility, we performed in vitro RAG1/2-mediated 
DNA-coupled cleavage assays which recapitulate the first step 
of V(D)J recombination reaction (i.e., DSB formation) and 
hence result in the release of signal ends (SEs) and coding ends 
(CEs). Using pD3J1 or pD2J1 substrates, we observed the re-
lease of D3-J1 SE, but no D2-J1 SE, respectively (Fig. 7 A). 
With the pD2D3J1 substrate, we detected only the presence of 
D2-D3 SE, indicating that even if D3 to J1 rearrangement 
is possible, it does not proceed before D2 to D3 rearrange-
ment (Fig. 7 A). Thus, the ordered assembly observed in vivo 
can be recapitulated in vitro with chromatin-free substrates.
Next, to functionally test the role of the RUNX1 bind-
ing site in D2-D3 rearrangement, we used the mutated 
p3D2mutD3J1 recombination substrate (Fig. 7 B). In vitro cou-
pled cleavage assays performed with p3D2mutD3J1, and as 
controls, p3D2D3J1 and pD3J1, showed that disruption of the 
RUNX1 binding site prevents D2-D3 SE formation but 
makes possible the production of D3-J1 SE (Fig. 7 B). There-
fore, the loss of RUNX1 binding onto D2-23RSS disrupts 
the cleavage order observed with the pD2D3J1 substrate.
To establish the role of RUNX1 in endogenous TCR- 
locus rearrangements, we first took advantage of the BOSC23 
cell line assay in which TCR- rearrangements can be induced 
(Langerak et al., 2001). As previously reported, when BOSC23 
cells were transfected with RAG1/RAG2/E47-expressing 
vectors, we observed a nonclassical rearrangement between 
To next test the hypothesis that RUNX1 recruits RAG1 to 
D2-23RSS, ChIP assays with anti–flag-RAG1 antibody were 
performed using 293T cells transfected with pD2D3J1 recom-
bination substrate vector. We observed that RAG1 binding to 
D2-23RSS is dependent on the presence of RUNX1 (Fig. 6 A). 
The presence of CBF-, but not RAG2, was necessary for 
RAG1 recruitment (unpublished data). The ChIP assay was then 
performed with a pD2mutD3J1 vector harboring a mutated 
RUNX1 binding site. This mutation corresponds to the addi-
tion of a guanine located within the D2 coding sequence and 
as such it keeps the D2-23RSS intact. Coding flank composi-
tion can affect V(D)J recombination (Ezekiel et al., 1997); how-
ever, this mutation, which changes the first nucleotide of the 
coding flank, has no major impact on RAG cleavage efficiency 
(Fig. 6 B, left). This assay was performed with RAG1/2-enriched 
crude extract complemented with a thymic protein extract con-
taining Runx1 protein (Fig. 6 B, right). In addition, this muta-
tion results in significant decrease in RUNX binding to 
D2-23RSS (Fig. 6 C). Importantly no enrichment of RAG1 
binding to D2-23RSS was observed, indicating that mutation 
of RUNX1 binding site abolished RAG1 recruitment onto the 
D2-23RSS (Fig. 6 A). Collectively, these data strongly suggest 
that during early thymopoiesis, RUNX1 and RAG1 function-
ally interact to induce RAG1 loading onto the D2-23RSS.
RUNX1 loss of function leads to absence  
of human D2-D3 rearrangements
We showed that, in vivo, the assembly of D2 and J1 gene 
segments occurs in a two-step process systematically including 
Figure 4. Binding of RUNX1 to the D2-23RSS. (A) Sequences of RSS (12 and 23) and coding segments (bold) for D2, D3, and J1. The RUNX1 
putative binding site in D2-23RSS is double underlined. (B) RQ-PCR for RUNX1 expression in human thymic subpopulations. Results (mean and SEM of 
triplicate reactions) are represented relative to the ABL1 housekeeping gene. (C) Western blot analysis of RUNX1 expression in human thymic subpopula-
tions. Shown is a representative of three Western blots. (D) Analysis by ChIP-QPCR assays of RUNX1 binding in human CD34+/CD3 cells. Enrichment 
level was determined by comparison to a standard curve from input DNA. D2-23RSS, D3-12RSS, and E DNA were amplified by RQ-PCR and normal-
ized to actin as negative control. IgG isotype control was performed to assess absence of nonspecific ChIP enrichment (not depicted). Errors bars repre-
sent SEM. (E) As in D, for mouse Rag2/ DN thymocytes. ChIP experiments are representative of at least two independent experiments.
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were then co-cultured on OP9-DL1 to promote T cell differ-
entiation. Cells were collected at days 8 and 11 for quantification 
of D2-D3 rearrangements. By day 11, D2-D3 rearrange-
ments were detected in sh-control-GFP conditions, whereas they 
were undetectable in RUNX1 knocked down cells (Fig. 8 C). 
Viability of sh-control-GFP and sh-RUNX1-GFP cells was 
monitored by Annexin-V/IP staining, which confirmed the 
absence of significant apoptosis in both conditions (Fig. 8 D). 
the upstream D2-12RSS and the downstream D3-23RSS, 
giving rise to D2-D3 SJ and elimination of the D2-D3 
CJ as an episomal circle (Fig. 8, A [left] and B). However, 
when BOSC23 cells were cotransduced with the RUNX1-
expressing vector, normal D2-D3 rearrangements occurred 
(Fig. 8, A [right] and B), indicating that RUNX1 is crucial 
for accurate TCR- locus rearrangement. To confirm this, 
RUNX1 was knocked down in UCB CD34+ cells which 
Figure 5. RUNX1–RAG1 interactions.  
(A) RAG1 interacts with RUNX1 but not  
CBF-. Cell lysates from 293T cells cotransfected 
with vectors expressing RAG1-Flag-SBP, 
RUNX1, and CBF- were precipitated with 
streptavidin (StP) beads and then immuno-
blotted (IB) with anti-RUNX1, anti–CBF-, and 
anti-Flag antibodies. Input represents 1% of 
cell lysate used for StP. FT: flow through; LW: 
last wash. In the control experiment, 293T 
cells were transduced with Flag-SBP empty 
vector instead of RAG1-Flag-SBP. A represen-
tative of two independent experiments is 
shown. (B) MOLT-4 cells lysates were immuno-
precipitated (IP) using anti-RUNX1 or con-
trol IgG antibody and then immunoblotted 
using an anti-RAG1 antibody. The input lanes 
correspond to 10% of cell extracts used in the 
Co-IP. No Ab: control IP experiment per-
formed without anti-RUNX1 antibody. FT: 
flow-through; LW: last wash. A representative 
of two independent experiments is shown.  
(C–G) Duolink PLAs and confocal microscopy 
analysis of cells labeled with anti-RAG1 mAb 
(Alexa Fluor 555, purple) and anti-RUNX1 
(Alexa Fluor 647, red). Shown is a representa-
tive of at least three independent experi-
ments. Bars, 10 µm. (C and D) PLA using 
MOLT-4 cell line before (C) and after (D) inac-
tivation of RUNX1 or RAG1. Western blots are 
shown on the right for RUNX1, RAG1, and 
actin expression from mock and knockdown 
cells. (E–G) PLA using CD34+ thymocytes (E) 
and CD34+ UCB after sort (D0; F) and after 7 d 
of culture (D7; G).
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(devoid of Runx1 protein), similar nonclassical rearrangements 
were observed; interestingly, in their discussion the authors 
anticipated our conclusion that a cofactor may dictate RAG 
binding to RSS (Olaru et al., 2005). Of note, the D3-J1 
The absence of RUNX1 in the co-cultured cells led to for-
mation of nonclassical rearrangements, where the coding seg-
ments D2 and D3 are deleted from the locus (Fig. 8 E). In 
ex vivo assays performed with nonlymphoid HEK293 cells 
Figure 6. RAG1 deposition onto D2-
23RSS. (A) ChIP assays performed with anti-
FLAG antibody (or control IgG antibody) and 293T 
cells transfected with the indicated recombina-
tion substrates and expression vectors. Enrich-
ment at substrate vectors is shown relative to 
input substrate vectors DNA and normalized to 
GFP control. Error bars represent standard devia-
tions from means. Presented data are from three 
independent experiments. (B) J1-VL8 recombi-
nation substrate containing RSS sequences of J1 
and VL8 (Franchini et al., 2009) was mutated to 
harbor the ACG coding sequence found in the 
mutated version of D2 gene segment. Left panel 
shows in vitro RAG cleavage assay of J1-VL8 
and ACGJ1-VL8. The amounts of RAG1/2 crude 
extract used for each in vitro RAG cleavage assay 
(around 30 µg) were loaded on SDS-PAGE, and 
then Runx1 protein expression was analyzed by 
Western blot (right). Shown is a representative of 
two experiments. (C) ChIP-QPCR assays per-
formed with anti-RUNX1 antibody (or control IgG 
antibody) and 293T cells transfected with the 
indicated recombination substrates and expres-
sion vectors. Enrichment at substrate vectors is 
shown relative to input substrate vectors DNA. 
Error bars represent standard deviations from 
means. IgG isotype control was performed to 
assess absence of nonspecific ChIP enrichment. 
Shown is a representative of two experiments.
Figure 7. Inhibition of RUNX1 binding 
disrupts the order of TCR- rearrange-
ment. (A and B) In vitro RAG1/2-mediated 
DNA-coupled cleavage assays. Top: schematic 
representation of plasmid substrates. 12 and 
23 RSS are represented by black and white 
triangles, respectively. Positions of radiola-
beled probes are indicated by gray (5J1 
probe) and black (3D2 probe) lines. Sizes of 
SE fragments are indicated. Bottom: autora-
diographs of Southern blot analyses of 
RAG1/2-mediated DNA coupled cleavage 
assays are representative of three indepen-
dent experiments. Blots were hybridized with 
the probe specified below autoradiographs. 
Bands corresponding to SE products are indi-
cated. § highlights SE D2J1 from pD2J1 vec-
tor. In B, RUNX1 binding site mutation is 
highlighted by an asterisk.
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recognized to be ordered (Khor and Sleckman, 2002; Jung 
et al., 2006) both in mouse and humans. In contrast, the TCR- 
locus was considered to not be ordered. The vast majority of 
these studies, however, focused on mouse thymic maturation, 
and little data were available for early human T cell maturation 
(Chiei et al., 1987; Krangel et al., 2004). One study suggested 
that the earliest human TCR- rearrangements could be or-
dered, based on the identification of predominant D2-D3 
rearrangements within a very immature (CD34+/CD1a) 
thymic subset (Dik et al., 2005). We now demonstrate that 
D2-D3 rearrangements do indeed occur before D2-J1 
rearrangements in a specific ETP subset of human thymocytes, 
highlighting differences in early mouse and human thymopoi-
esis (Blom et al., 1998). Importantly we show that this ordered 
TCR- rearrangement involves RUNX1, which binds to 
human D2-23RSS (but not to the homologous mouse D1-
23RSS), recruits RAG1, and imposes D2 to D3 rearrange-
ment before D3 to J1 rearrangement. A similar scenario was 
described for the ordering of TCR- gene assembly by the 
c-Fos TF on D 23RSS (Wang et al., 2008). Collectively, these 
data indicate that TF-mediated RAG1 deposition onto a given 
rearrangements observed above in chromatin-free substrate 
experiments were observed neither in RUNX1 knocked 
down CD34+ UBC co-cultured on OP9-DL1 cells nor in the 
BOSC23 cell line assay without RUNX1 (unpublished data). 
This difference between in vivo and in vitro experiments re-
mains unexplained and requires further investigations.
Collectively, these results demonstrate that human TCR- 
rearrangements occur through an ordered two-step process 
which is controlled by beyond chromatin accessibility mecha-
nisms. First, a B12/23 restriction impedes direct D2 to J1 
rearrangements and thus insures D3 gene segment utiliza-
tion. Second, ordered rearrangements (D2 to D3 precedes 
D3 to J1) require the RUNX1 TF for RAG1 deposition 
on D2-23RSS.
DISCUSSION
Among antigen receptor loci, only TCR-, Ig heavy chain 
(IgH), and TCR- contain D segments. The TCR- and 
TCR- loci share particularly similar structural features and 
harbor the same RSS distribution. The regulation of TCR- 
and IgH, which both show allelic exclusion, has long been 
Figure 8. RUNX1 is necessary for proper initiation of early T cell rearrangements. (A and B) Products of TCR- gene rearrangements in the BOSC23 
non lymphoid human cell line. (A) Schematic representation of TCR- rearrangements when BOSC23 cells are transduced with RAG1-, RAG2-, and E47-
expressing vectors (left) or with RAG1-, RAG2-, and RUNX1-expressing vectors (right). 12 and 23 RSS are represented by black and white triangles, respec-
tively. (B) Sequences of detected D2-D3 rearrangements representative of two independent experiments. (C) RQ-PCR quantification of D2-D3 
rearrangements in CD34+ UCB cells transduced with control sh-control-GFP and sh-RUNX1-GFP and cultured onto OP9-DL1 during 8 and 11 d (gray and 
black bars, respectively). Results (mean and SEM representative of three independent experiments) are normalized to the Albumin gene. (D) Flow cytometric 
analysis of CD34+ UCB cells after transduction with lentiviruses encoding the GFP protein and control or RUNX1-specific shRNAs. GFP+-transduced cells 
were gated for analysis of Annexin V/PI staining. Flow cytometry plots representative of three independent experiments. (E) Detection of the nonclassical 
D2-D3 rearrangements in the experiment of Runx1 knockdown in UCB CD34+ cells. Sequences are representative of three independent experiments.
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A recent study described a role for Runx1 in early B lympho-
cyte development, whereby Runx1 activates the expression of 
the TF Ebf1 that is required for VH to DH-JH rearrangement 
(Seo et al., 2012). The mechanistic role of Runx1 in IgH locus 
assembly seems, however, to be quite distinct from the direct 
TCR- RSS-binding and RAG deposition described here.
This role for RUNX1 in “RAG1 deposition” on D2-
23RSS is likely to be particularly important at the early stages 
of T cell development, when RAG1 expression is low. Con-
sistent with the “nonamer first” model (Schatz and Ji, 2011), 
we suggest that RAG1 interacts primarily with the nonamer, 
whereas RUNX1 binds to the coding/heptamer junction; the 
D2-23RSS may, therefore, be able to accommodate both 
proteins, which could even cooperate in DNA binding, at 
least initially. Cooperative binding has been evidenced for 
RUNX1 and ETS1, whose interaction increases their affinity 
for their juxtaposed DNA binding sites, notably in TCR reg-
ulatory elements (Kim et al., 1999). Such cooperative interac-
tions had up till now not been identified in the context of 
early TCR- rearrangements.
The probability that a coding/heptamer junction harbors 
a RUNX1 binding site, d(A1C2C3A4C5A6), is not negligible 
because most of the RSS heptamers start with d(C3A4C5A6) 
and all of them possess at least the d(C3A4C5) sequence, which 
is absolutely required for RAG cleavage. Despite this, we 
found only one RSS carrying a RUNX1 binding site among 
the human TCR- D and J segments. An in-depth analysis 
of RUNX1-RSS sequences in Ig/TCR V, D, and J segments 
will further clarify the potentially variable roles of RUNX1 
in human and mouse lymphoid development. Our data are 
compatible with different roles for RUNX1 in the initiation 
of T lymphopoiesis in mice and men, which if confirmed, has 
profound impact for the extrapolation of mouse models to 
human T lymphopoiesis.
The human genome is peppered with RUNX1 binding 
sites and RUNX1 is involved in the regulation of various 
genes during hematopoietic differentiation (Wong et al., 
2011). The downside of RAG1–RUNX1 interaction is that 
RUNX1 might mis-target RAG1 and induce genomic insta-
bility by creating illegitimate DNA nicks or double-strand 
breaks at nonantigen receptor loci. Chromosomal rearrange-
ments involving TCR loci are frequent in T-ALL and are not 
purely RAG mediated. We have recently shown that the vast 
majority of TCR- translocations occur during TCR- D2-
D3, potentially suggesting a role for RUNX1 in their patho-
genesis (Dadi et al., 2012: Le Noir et al., 2012). The RUNX1 
gene is one of the most frequently mutated genes in human 
leukemia; RUNX1 loss-of-function or dominant-negative 
fusion proteins result in leukemia-prone cells which become 
fully leukemic upon acquisition of additional hits (Speck and 
Gilliland, 2002). More specifically, RUNX1 loss-of-function 
mutations occur in 25% of the most immature subset of 
acute myeloid leukemia (AML-M0; Preudhomme et al., 2000). 
Based on the data presented here, it is tempting to speculate 
that the maturation arrest in these rare AML may be, at least in 
part, related to a failure to initiate TCR- rearrangement.
RSS represents a recurrent mechanism of control of the start 
of V(D)J recombination in thymopoiesis. It has been previ-
ously shown that TCR- rearrangement evolves in an age-
dependent manner; in contrast to postnatal thymocytes, in fetal 
thymus TCR- chains contain only one D segment (D3) 
and display almost no N-nucleotide incorporation (Krangel 
et al., 1990). It is tempting to speculate that Runx1 is involved 
in this developmental shift from early fetal to postnatal pattern 
of TCR- rearrangement, and thus that TF-dependent re-
cruitment of the RAG complex to RSS may represent mecha-
nism of developmental control of V(D)J recombination.
The minor TCR-–expressing T cell (T cell) popula-
tion has been conserved throughout vertebrate evolution, 
indicating a nonredundant function of those cells compared 
with TCR- T cells. T cells contribute to immune re-
sponses by combining innate and adaptive features (Vantourout 
and Hayday, 2013). TCR- ligands are not yet fully charac-
terized but they clearly differ from antigens recognized by 
T cells which consist of processed peptides presented by the 
major histocompatibility complex. The D region encodes the 
third complementary determining region (CDR3) and tan-
dem use of two D gene segments is specific to TCR- chains. 
A consequence of our data are that, in human TCR- locus 
V(D)J recombination, RUNX1 imposes the use of two D 
gene segments in all rearranged TCR- chains, suggesting an 
important functional role of the length (and diversity) of the 
TCR- CDR3. Importantly, the average mouse TCR- 
CDR3 is shorter than that observed in humans (Rock et al., 
1994), suggesting an evolutionary advantage acquired (and im-
posed by the RUNX1 D2-23RSS site) in humans compared 
with mice. These observations merit functional investigation 
to establish the role of this mechanism in human and mouse 
TCR- immune responses.
RUNX1, RUNX2, and RUNX3 are members of the 
RUNX family of TF; they share a conserved Runt domain, 
which mediates DNA binding and heterodimerization with 
the CBF- protein. RUNX1 is the predominantly expressed 
RUNX factor in the hematopoietic system, where it is essen-
tial for definitive hematopoiesis during embryogenesis. Runx1 
gene inactivation in mice impedes the emergence of the first 
hematopoietic stem cells (HSCs) from the aorto-gonadal- 
mesonephros region. In adult mice, inactivation of Runx1 
impairs lymphoid and megakaryocyte lineage maturation 
(Ichikawa et al., 2004; Growney et al., 2005) and leads to HSC 
exhaustion, although this is still under debate ( Jacob et al., 
2010; Cai et al., 2011). Deletion of Runx1 at either DN or 
DP stages of T cell differentiation using Lck-cre or CD4-cre 
transgenic mice, respectively, showed that Runx1 is required 
for DN3 to DN4 and DP to single positive (SP) CD4+ tran-
sitions (Taniuchi et al., 2002; Egawa et al., 2007). RUNX1 
binding sites are present in human and murine TCR- and 
TCR- enhancers, which are essential for TCR- and TCR-  
expression (Sleckman et al., 1997; Tripathi et al., 2002). Herein, 
we identify a new function for RUNX1 during the early 
stages of human thymic development whereby it acts as 
a RAG1 cofactor for the start of TCR- rearrangement. 
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addition of the RAG1/2 extract. After extraction and precipitation, the DNA 
samples were analyzed by Southern blot using a Hybond N transfer mem-
brane (GE Healthcare). Membranes were hybridized with TCR-–specific, 
radiolabeled probes 3D2 (5-TTGCTGGAGCTTGAC-3) or 5J1 
(5-GGGTAAGCAACAAGTGCC-3).
ChIP. ChIP assays were performed, with modifications, according to the 
manufacturer’s instructions (Agilent Technologies). In brief, thymocytes 
were cross-linked for 20 min with 1% formaldehyde and sonicated using 
an Ultrasonics sonicator (Vibra-cell VCX130; SONICS) to obtain a mean 
length for DNA fragments of 600 bp. After immunoprecipitation with 
anti-RUNX1 antibody, ChIP DNA was purified by phenol/chloroform 
extraction and a QiaQuick PCR Purification kit (QIAGEN). Samples 
were analyzed by RQ-PCR with the following human primers: D2-
23RSS forward, 5-AGCGGGTGGTGATGGCAAAGT-3; D2-23RSS 
probe, 5-AGAAGAGGGTTTTTATACTGATG-3; D2-23RSS reverse, 
5-AGACATACATAGCGGGTCAC-3; D3-12RSS forward, 5-CTA-
ACTGTCAGGACCCTTTGATCTT-3; D3-12RSS probe, 5-ATACG-
CACAGTGCTACAAAACCTACAGAGACCT-3; D3-12RSS reverse, 
5-TTGCCCCTGCAGTTTTTGTAC-3; E forward, 5-TTCCAT-
GACGTCATGGTTACC-3; E reverse, 5-GCGATGCTATCTCTAA-
CTCAG-3; Actin forward, 5-CTCCCATTGTCTACCTCAGTTTC-3; 
and Actin reverse, 5-CTTATGTGCTGAGAAGGTGGTG-3. Mouse thy-
mocytes were purified from 4-wk-old Rag2/ mice (Shinkai et al., 1992) 
bred on a C57BL/6J background. ChIP against Runx1 (Abcam) was per-
formed as previously described (Koch et al., 2011). The ChIP sample was 
analyzed by RQ-PCR with the following mouse primers: negative control 
forward, 5-CCCCTTTCTGAAGCACTCTG-3; negative control reverse, 
5-TAAGGCGTCATTTCCCAAAG-3; E forward, 5-TGCTGACAT-
GGGCAAACAGGTC-3; E reverse, 5-ACTCCTCTTTCCAGAGGAT-
GTGGC-3; RSS-D1forward, 5-TGGGTATGGCAGAGGGTGGT-3; 
RSS-D1 reverse, 5-TGCCATCACAGTGAAACACAGCCG-3; RSS-
D2 forward, 5-TGTAGCACCGTGATCGGAGGGA-3; and RSS-D2 
reverse, 5-AGGCCTGGGAGACGGTTCTT-3. For ChIP analysis of RAG1 
binding, 293T cells were transfected with appropriate plasmids using lipo-
fectamine (Invitrogen). 30 h after transfection, cells were cross-linked with 
1% formaldehyde for 10 min then lysed and sonicated. Finally, immuno-
precipitation of RAG1-Flag-SBP was performed using anti-FLAG antibody 
(Sigma-Aldrich). For analysis of ChIP samples by RQ-PCR, the forward 
primer complementary to T7 promoter of p-GEMT-easy vector T7 forward 
(5-TAATACGACTCACTATAGG-3) and the D2 reverse primer (5-AA-
CACATCAGTATAAAAACCC-3) were used.
Immunofluorescence. Cells were fixed on slides using poly-L-lysine, and 
Duolink (Duolink II; Olink Biosciences) assay was performed according to 
the manufacturer’s instructions. In brief, cells were fixed with formaldehyde 
2% for 15 min, permeabilized with Triton X-100 1% for 10 min, and incu-
bated with RUNX1 (1/1,000) and RAG1 (1/25) antibodies for 1 h at room 
temperature. Images were collected on a confocal microscope (LSM 700; 
Carl Zeiss) with Zen 2011 software using 63× objectives at room tempera-
ture. Images were processed using ImageJ (National Institutes of Health).
Cell lines and T cell differentiation. The MOLT-4 cell line was cultured 
in RPMI-1640 medium supplemented with 50 µg/ml streptomycin, 50 IU 
penicillin, and 20% FBS at 37°C in a humidified atmosphere of 5% CO2. 
BOSC23 and 293T cell lines were maintained in Dulbecco’s modified Eagle 
medium with 10% FBS and antibiotics.
T cell differentiation was performed as previously described (Six et al., 
2011). In brief, CD34+ UCB cells were sorted and cultured on confluent 
OP9-DL1 in home made -MEM medium (Invitrogen) supplemented with 
20% FBS (Hyclone; Thermo Fisher Scientific) and cytokines (5 ng/ml rhFLT3-L, 
10 ng/ml rhSCF, and 2 ng/ml rhIL7; Miltenyi Biotec). DNA was extracted at 
different days of culture. Cord blood samples, harvested with informed consent, 
were obtained from Saint-Louis Hospital Cord Blood Bank, which is autho-
rized by the French Regulation Agency (reference TCG/12/R/004).
MATERIALS AND METHODS
Purification of thymocyte fraction. Thymii were obtained as surgical 
tissue discards from children, with informed consent from the parents and 
the ethical review board of Necker Enfants Malades Hospital at Paris Des-
cartes. Thymocytes were prepurified by magnetic-activated cell-sorted beads 
before sorting (FACSAria III; BD). Purity after sort was >95%.
Plasmids. The plasmids pD3J1, pD2D3J1, and p3D2D3J1 were generated 
by PCR using placental DNA and cloned into p-GEMT-easy vector. The 
plasmid substrate p3D2mutD3J1 was derived from p3D2D3J1 using site-
directed mutagenesis (Agilent Technologies). The plasmid pD2J1 was gen-
erated from pD2D3J1.
Vector pCMV5-RUNX1 was bought from Addgene (plasmid 12426). cDNA 
for CBF- was cloned into pEGFPC1. RAG1-Flag-SBP and pHAPneo-E47 
were gifts from D. Payet-Bornet and A.W. Langerak, respectively.
Antibodies used. For ChIP, immunoprecipitation, and WB, anti-RUNX1 
(Abcam), RAG1 (D36D3; Cell Signaling Technology), anti-FLAG (Sigma-
Aldrich), anti–CBF- (Abcam), and normal rabbit IgG (Santa Cruz Biotech-
nology, Inc.) were used. For immunofluorescence, RAG1 (D36D3) and 
RUNX1 (Abcam) were used. For flow cytometry, CD1a-FITC (NA1/34), 
CD13-FITC (WM47; Dako); CD3–Alexa Fluor 700 (UCHT1), CD4-V450 
(RPA-T4), CD5-PerCP-Cy5.5 (L17F12), CD7-PE (M-T701), CD8-APC 
(RPA-T8), CD34-PerCP-Cy5.5 (8G12), CD45-V500 (H130), HLA-DR-
FITC (L243), CD34-APC (8G12; BD); CD117-PECy7 (104D2D1; Beckman 
Coulter); and CD123-APC (AC145; Miltenyi Biotec) were used.
TCR rearrangement and TREC quantification. TCR- quantification 
(D2-D3, D2-J1, and D3-J1) was performed as previously described (Dik 
et al., 2005) with the listed sets of primers and probes. The following were used 
for D2-D3 rearrangements: D2, 5-CAAGGAAAGGGAAAAAGGAA-
GAA-3; D3, 5-TTGCCCCTGCAGTTTTTGTAC-3; and D3 probe, 
5-ATACGCACAGTGCTACAAAACCTACAGAGACCT-3. The follow-
ing were used for D2-J1 rearrangements: D2, 5-AGCGGGTGGTGAT-
GGCAAAGT-3; J1, 5-TTAGATGGAGGATGCCTTAACCTTA-3; and 
J1 probe, 5-CCCGTGTGACTGTGGAACCAAGTAAGTAACTC-3. The 
following were used for D3-J1 rearrangements: D3, 5-GACTTGGAGA-
AAACATCTGGTTCTG-3; and J1 and the J1 probe (listed above). TREC 
quantification was performed using an RQ-PCR mixture of 25 µl containing 
SYBR green (Applied Biosystems), 800 nM of each primer, 0.4 µg bovine 
serum albumin, and 100 ng genomic DNA. Normalization was performed 
with the Albumin gene for all targets.
The analysis of rearrangements by multiplex fluorescent PCR was per-
formed by separation of fluorochrome-labeled single stand (denaturated) 
PCR products in a capillary sequencing polymer and detected via automated 
laser scanning. The results as a Gaussian distribution of multiple peaks repre-
sent many different PCR products in case of polyclonal rearrangements.
BOSC23 cells were transfected with appropriate plasmids using lipo-
fectamine according to manufacturer’s conditions. 3 d after transfection, the 
cells were harvested and DNA was extracted. To verify the presence of rear-
rangements, PCR was performed as previously described (Langerak et al., 
2001) with the following primers: D25’ forward, 5-AGCGGGTGGTGAT-
GGCAAAGT-3; and D33’ reverse, 5-TGGGACCCAGGGTGAGGATAT-3. 
PCR product was cloned into p-GEMT-Easy vector and sequenced.
RAG1/2-mediated DNA cleavage in vitro assays. RAG1/2-mediated 
coupled cleavage was performed as previously described (Franchini et al., 
2009). Core RAG1 and RAG2 proteins were overexpressed in D10 cells (de-
rived from B lymphoma M12 cell line; Leu and Schatz, 1995), and for the 
assay, RAG1/2-enriched crude extract was complemented with thymic pro-
tein extract. In brief, 1 µg plasmid was incubated with RAG1/2 for 2 h at 
30°C in cleavage reaction buffer (50 mM HEPES-KOH, pH 7.5, 73 mM 
KCl, 2 mM NaCl, 10 mM MgCl2, and 1 mM DTT) supplemented with 
1.5 mM rATP and 6 mg of a nuclear extract prepared from mouse WT thy-
mocytes. Negative controls were performed using similar conditions without 
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